CATALENT LAUNCHES UPTEMPO℠ CAR-T CELL THERAPY PLATFORM, A FULLY CLOSED GMP-COMPLIANT WORKFLOWLearn More CATALENT EXPANDS UPTEMPO℠ AAV PLATFORM TO ACCELERATE DEVELOPMENT OF GENE THERAPIESLearn More BIOLOGICS CDMOCreate better biologic treatments and speed your path to market with our range of advanced technologies and services.Learn More How can we work together BIOLOGICS GENE THERAPY CELL THERAPY TECHNOLOGIES Latest News IsomAb Announces Strategic Collaboration with Catalent CELL THERAPY Catalent enables fully integrated cell therapy services, from iPSC differentiation, development, and manufacturing expertise, to process and analytical development across cell types, to clinical and commercial manufacturing in the United States and Europe. UPTEMPO℠ AAV PLATFORM PROCESS A scalable, cGMP-ready process providing early-stage partners with accelerated timelines for production of their clinical material FORMULATION DEVELOPMENT The formulation scientists at Catalent Biologics have experience in a variety of formulations and product presentations to help you develop and deliver your clinical or commercial formulation, faster. BIOLOGICS ANALYTICAL METHODS: TRENDS AND STRATEGIES TO ACCELERATE BIOLOGICS DEVELOPMENT In this webinar, experts describe how the stepwise approach for bioanalytical testing can be used to reduce risks and challenges present in biologics development. BIOLOGICS NETWORK Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world. LEARN MORE JOIN OUR TEAM Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team. NEWS IsomAb Announces Strategic Collaboration with Catalent Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer Catalent and JLABS Symposium to Discuss Accelerated Development and Manufacturing of Biologics Catalent Expands OneBio® Suite for Integrated Development, Manufacturing and Supply Across Biologic Modalities VIEW ALL NEWS EVENTS Leveraging Platform Processes for Developing and Accelerating Novel Gene and Cancer Therapeutics VIEW ALL EVENTS EXPERT CONTENT GPEx® Lightning: Achieving Rapid, High-Titer Expression for Next-Generation Biologics White Paper – Biocapacitance Measurement: A PAT Tool for Biomass Measurement in an Upstream Process GMP-Compliant iPS Cell Lines Show Widespread Plasticity in a New Set of Differentiation Workflows for Cell Replacement And Cancer Immunotherapy Webinar E-summary UpTempo℠ Antibody: A Streamlined Platform Process to Accelerate Biotherapeutics from Gene to Clinic VIEW ALL ARTICLES
